Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M13,391Revenue $M--Net Margin (%)--Altman Z-Score
Enterprise Value $M13,391EPS $--Operating Margin %--Piotroski F-Score--
P/E(ttm)14.8Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book1.510-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %2.9PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M100,000,000ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with VEU

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
VEUFirst Eagle Investment 2015-12-31 Reduce-0.01%$42.41 - $46.01
($44.45)
$ 44.34-0%Reduce -86.72%9,800
VEUFirst Eagle Investment 2015-06-30 Buy 0.01%$48.19 - $51.7
($50.15)
$ 44.34-12%New holding73,800
VEUKen Fisher 2013-03-31 Buy $45.45 - $47.27
($46.5)
$ 44.34-5%New holding9,230
VEUJoel Greenblatt 2011-06-30 Sold Out -0.35%$47.24 - $52.01
($49.43)
$ 44.34-10%Sold Out0
VEUJoel Greenblatt 2011-03-31 Add0.27%$45.42 - $49.81
($48.47)
$ 44.34-9%Add 353.24%23,677
VEUJoel Greenblatt 2010-12-31 Buy 0.08%$45.1 - $49.17
($47.23)
$ 44.34-6%New holding5,224
VEUWilbur Ross 2009-12-31 Sold Out -1.36%$41.6 - $45.36
($43.97)
$ 44.341%Sold Out0
VEUWilbur Ross 2009-09-30 Buy 1.36%$34.43 - $43.85
($39.8)
$ 44.3411%New holding190,300
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

VEU is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


VEU: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Dubuc, PhilippeSenior Officer 2016-04-08Buy1,700$1.992128.14view
Dubuc, PhilippeSenior Officer 2016-04-08Buy3,300$22117view
PAMPLIN, Ann-Marie MichelleDeemed Insider - 6 Months before becoming Insider 2016-04-08Buy10,000$0.1529460view
Williams, Allan WilliamSenior Officer 2016-04-08Buy108,500$0.1140209.09view
Stefura, Naomi MarieSenior Officer 2016-04-08Sell4,200$14.6203.7view
Gentiletti, NelsonDirector or Senior Officer of Insider or Subsidiar 2016-04-08Sell800$20.78113.38view
Gentiletti, NelsonDirector or Senior Officer of Insider or Subsidiar 2016-04-08Sell400$20.77113.48view
Gentiletti, NelsonDirector or Senior Officer of Insider or Subsidiar 2016-04-08Sell300$20.75113.69view
Gentiletti, NelsonDirector or Senior Officer of Insider or Subsidiar 2016-04-08Sell100$20.72114view
Gentiletti, NelsonDirector or Senior Officer of Insider or Subsidiar 2016-04-08Sell900$20.7114.2view

Quarterly/Annual Reports about VEU:

    News about VEU:

    Articles On GuruFocus.com
    What A Wonderful Market (And Where This Leads Us) Jul 07 2014 

    More From Other Websites
    Will Valeant Pharmaceuticals Recover after Appointing a New CEO? Apr 29 2016
    The 3 Largest Global Ex-U.S. ETFs (VEU, VXUS) Apr 28 2016
    Valeant Pharmaceuticals’ 10-K for 2015: The Wait Continues Apr 28 2016
    4 Ways an Economy Can Deleverage: Ray Dalio Explains Apr 26 2016
    What Economic Factors Will the UK Consider in the Brexit Decision? Apr 19 2016
    How Much Potential Does Saxenda Hold for Novo? Apr 17 2016
    Why Have HollyFrontier’s Cash Reserves Fallen Steeply? Apr 17 2016
    Developing Nations Increase Borrowing Apr 17 2016
    US Factory Orders Fell in February: What Does It Mean? Apr 11 2016
    Teva’s Asthma Segment: What Could Its Boost Revenues in 2016? Apr 06 2016
    Analyzing Valero’s Cash Flow: Increasing Shareholders’ Returns Apr 06 2016
    Foreign Equities Turning Lower Again Apr 06 2016
    How Has HFC’s Stock Performed since February 2016? Mar 31 2016
    How Could Generic Competition Affect Copaxone’s Revenues in 2016? Mar 30 2016
    Service Sector Helped France’s PMI Index Rise in March Mar 29 2016
    Six Advanced Studies for Roche’s Atezolizumab Mar 28 2016
    Inside Roche’s Next Oncology Portfolio Drivers Mar 28 2016
    Does Consolidation Favor A Big Move Up Or Down? Mar 25 2016
    7 Vanguard ETFs Reducing Fees in 2016 (VEU, VSS) Mar 23 2016
    (VEU) Vanguard All World ex-US. ETF: Top 5 Holdings Mar 19 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)